Medidata Reaches New 52-Week High (MDSO)

NEW YORK ( TheStreet) -- Medidata Solutions (Nasdaq: MDSO) hit a new 52-week high Friday as it is currently trading at $27.05, above its previous 52-week high of $26.53 with 42,687 shares traded as of 9:40 a.m. ET. Average volume has been 191,000 shares over the past 30 days.

Medidata has a market cap of $509.5 million and is part of the technology sector and computer software & services industry. Shares are up 17.8% year to date as of the close of trading on Thursday.

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. The company has a P/E ratio of 16, above the average computer software & services industry P/E ratio of 14.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medidata as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Medidata Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.